What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee

scientific article

What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/HUMREP/DEP476
P698PubMed publication ID20124394
P5875ResearchGate publication ID41399485

P50authorCéline MoutouQ96155904
P2093author name stringJoanne Traeger-Synodinos
Martine De Rycke
Joep Geraedts
Katerina Vesela
Joyce Harper
Veerle Goossens
Francesco Fiorentino
Gary Harton
Edith Coonen
Pam Renwick
Sioban Sengupta
Tugce Pehlivan Budak
P2860cites workHigh resolution array-CGH analysis of single cellsQ33267061
ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007.Q33436560
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial.Q34357019
What next for preimplantation genetic screening? High mitotic chromosome instability rate provides the biological basis for the low success rateQ37390000
Preimplantation genetic screening to improve in vitro fertilization pregnancy rates: a prospective randomized controlled trialQ40146578
Preimplantation genetic screening outcomes are associated with culture conditionsQ43422450
A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patientQ48738473
Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trialQ48741471
Assessment of numeric abnormalities of X, Y, 18, and 16 chromosomes in preimplantation human embryos before transfer.Q50762701
Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer.Q51678170
Chromosome instability is common in human cleavage-stage embryos.Q53398239
What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy.Q53472614
Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation ratesQ57779232
Will preimplantation genetic diagnosis assist patients with a poor prognosis to achieve pregnancy?Q57779472
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)821-823
P577publication date2010-02-02
P1433published inHuman ReproductionQ5937357
P1476titleWhat next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee
P478volume25

Reverse relations

cites work (P2860)
Q38031577A methodological overview on molecular preimplantation genetic diagnosis and screening: a genomic future?
Q36434649A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice
Q50913286Adjuncts in the IVF laboratory: where is the evidence for 'add-on' interventions?
Q35357388Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles
Q34944766Blood pressure and anthropometrics of 4-y-old children born after preimplantation genetic screening: follow-up of a unique, moderately sized, randomized controlled trial
Q56973422Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy
Q95826815Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology
Q37828026Delayed childbearing: effects on fertility and the outcome of pregnancy
Q37059959Discrepant diagnosis rate of array comparative genomic hybridization in thawed euploid blastocysts
Q53289190Does additional hybridization also improve preimplantation genetic screening results?
Q28286723Dynamics and ethics of comprehensive preimplantation genetic testing: a review of the challenges
Q33683144ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008.
Q34263818ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009.
Q30970981ESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011.
Q47622050ESHRE PGD Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013.
Q85239152ESHRE PGD Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS)
Q38590592Elective Single Embryo Transfer: an update to UK Best Practice Guidelines
Q47724353Genetic diseases and aneuploidies can be detected with a single blastocyst biopsy: a successful clinical approach
Q48493269Genetics and bioethics: how our thinking has changed since 1969.
Q38575047How should we choose the 'best' embryo? A commentary on behalf of the British Fertility Society and the Association of Clinical Embryologists
Q39274880Karyomapping and how is it improving preimplantation genetics?
Q36390581Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women
Q26822576Metabolomic assessment of embryo viability
Q36035686Multiple meiotic errors caused by predivision of chromatids in women of advanced maternal age undergoing in vitro fertilisation
Q35887436New array approaches to explore single cells genomes
Q36342048New protocol based on massive parallel sequencing for aneuploidy screening of preimplantation human embryos.
Q34113055OMICS: Current and future perspectives in reproductive medicine and technology
Q38282802Polar bodies in assisted reproductive technology: current progress and future perspectives
Q35389273Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results
Q90258032Prediction of the in vitro developmental competence of early-cleavage-stage human embryos with time-lapse imaging and oxygen consumption rate measurement
Q44400550Preimplantation diagnosis--PID: preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)
Q37691155Preimplantation genetic diagnosis guided by single-cell genomics
Q47120861Preimplantation genetic diagnosis: an update on current technologies and ethical considerations
Q34199663Preimplantation genetic diagnosis: state of the art 2011.
Q38671062Preimplantation genetic screening
Q37300095Preimplantation genetic screening (PGS) with Comparative genomic hybridization (CGH) following day 3 single cell blastomere biopsy markedly improves IVF outcomes while lowering multiple pregnancies and miscarriages.
Q24244735Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection
Q36068679Preimplantation genetic screening for all 24 chromosomes by microarray comparative genomic hybridization significantly increases implantation rates and clinical pregnancy rates in patients undergoing in vitro fertilization with poor prognosis
Q34199329Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo?
Q38864772Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences?
Q46297164Production of offspring after sperm chromosome screening: an experiment using the mouse model
Q34334104Singling out genetic disorders and disease
Q34724819The 'thousand-dollar genome': an ethical exploration
Q33592827The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing
Q36758994The impact of patient preselection on reported IVF outcomes
Q38132735Twenty years of Cochrane reviews in menstrual disorders and subfertility.
Q47311284Vorsprung durch Technik: On biotechnology, bioethics, and its beneficiaries
Q41606774When and how should new technology be introduced into the IVF laboratory?
Q30391597Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics

Search more.